Biotech Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology December 18, 2025
Biotech Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Induction Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on December 16, 2025 December 17, 2025
Biotech Ascletis Announces Positive Topline Results from U.S. Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor December 16, 2025
Biotech Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout December 15, 2025
Biotech NanOlogy Unveils Drug Development Program for Rare Pediatric Brainstem Tumor December 14, 2025
Biotech BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair December 11, 2025
Biotech GC Genome Study Identifies ‘Confounders’ Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy December 10, 2025